98 related articles for article (PubMed ID: 19747969)
1. Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles.
Chakravarthi SS; De S; Miller DW; Robinson DH
Int J Pharm; 2010 Jan; 383(1-2):37-44. PubMed ID: 19747969
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles.
Chakravarthi SS; Robinson DH
Int J Pharm; 2011 May; 409(1-2):111-20. PubMed ID: 21356285
[TBL] [Abstract][Full Text] [Related]
3. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
4. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
Harper E; Dang W; Lapidus RG; Garver RI
Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
[TBL] [Abstract][Full Text] [Related]
5. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells.
Wang C; Ho PC; Lim LY
Int J Pharm; 2010 Nov; 400(1-2):201-10. PubMed ID: 20804835
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
Mo Y; Lim LY
J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
[TBL] [Abstract][Full Text] [Related]
7. In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.
Kumar Naraharisetti P; Yung Sheng Ong B; Wei Xie J; Kam Yiu Lee T; Wang CH; Sahinidis NV
Biomaterials; 2007 Feb; 28(5):886-94. PubMed ID: 17067667
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW
Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
[TBL] [Abstract][Full Text] [Related]
11. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
13. Magnetic paclitaxel nanoparticles inhibit glioma growth and improve the survival of rats bearing glioma xenografts.
Zhao M; Liang C; Li A; Chang J; Wang H; Yan R; Zhang J; Tai J
Anticancer Res; 2010 Jun; 30(6):2217-23. PubMed ID: 20651372
[TBL] [Abstract][Full Text] [Related]
14. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery.
Xu Z; Gu W; Huang J; Sui H; Zhou Z; Yang Y; Yan Z; Li Y
Int J Pharm; 2005 Jan; 288(2):361-8. PubMed ID: 15620876
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
[TBL] [Abstract][Full Text] [Related]
18. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres.
Tzafriri AR; Lerner EI; Flashner-Barak M; Hinchcliffe M; Ratner E; Parnas H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):826-34. PubMed ID: 15701873
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
20. [VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma].
He YJ; Lin TT; Zhu LM; Luo H; Chang J; Zhang H; Zhang HM
Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):795-801. PubMed ID: 21092558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
